Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 12, 2022

SELL
$117.13 - $176.59 $10,073 - $15,186
-86 Closed
0 $0
Q1 2022

Apr 29, 2022

BUY
$126.46 - $235.05 $10,875 - $20,214
86 New
86 $15,000
Q4 2021

Feb 15, 2022

SELL
$225.82 - $368.51 $18,065 - $29,480
-80 Closed
0 $0
Q3 2021

Nov 12, 2021

SELL
$221.9 - $484.47 $10,651 - $23,254
-48 Reduced 37.5%
80 $31,000
Q3 2020

Nov 16, 2020

BUY
$54.34 - $94.85 $6,955 - $12,140
128 New
128 $9,000

Others Institutions Holding MRNA

About Moderna, Inc.


  • Ticker MRNA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 391,200,000
  • Market Cap $45.4B
  • Description
  • Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...
More about MRNA
Track This Portfolio

Track Capital Advisory Group Advisory Services, LLC Portfolio

Follow Capital Advisory Group Advisory Services, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Capital Advisory Group Advisory Services, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Capital Advisory Group Advisory Services, LLC with notifications on news.